Global Pharmaceutical Company - Ranbaxy

WASHINGTON (AP) -- The government is closing U.S. borders to more than 30 generic drugs - including popular antibiotics and cholesterol medicines - made by India's drug giant Ranbaxy Laboratories because of poor quality in two of its factories.

The Food and Drug Administration says consumers who already have the drugs shouldn't worry: Repeated testing hasn't found any contamination, and Ranbaxy can continue selling medicines made at any of its other factories.

The showdown instead is over what the FDA says is Ranbaxy's failure to correct significant manufacturing problems that could lead to sub-potent drugs, allergic reactions or other problems.

The move also may affect a U.S. program that sends AIDS drugs to Africa, for which Ranbaxy is a leading supplier.


My Response: My main concern revolves around the following question, "Why are these drugs still on the self?" Obviously the U.S. knows there is a problem with the generic drugs being produce from this pharmaceutical company, so why aren't they pulling them from the self.

Per my research on Ranbaxy, it is one of the biggest pharmaceutical companies in the world. Below are some facts about Ranbaxy's global mission statement.

"Driven by innovation and speed to market we focus on delivering world-class generics at an affordable price. Our unwavering determination to achieve excellence leads us to new global benchmarks. Our people have consistently risen above all challenges maximized opportunities and positioned Ranbaxy as a leader in the global generics space.

Ranbaxy’s global footprint extends to 49 countries embracing different locales and cultures to form a family of 51 nationalities with an intellectual pool of some of the best minds in the world. "

http://www.ranbaxy.com/operations/operations.aspx